Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Taxes (2020 - 2025)

Ironwood Pharmaceuticals' Current Taxes history spans 5 years, with the latest figure at $927000.0 for Q4 2025.

  • For Q4 2025, Current Taxes rose 77.93% year-over-year to $927000.0; the TTM value through Dec 2025 reached $927000.0, up 77.93%, while the annual FY2025 figure was $927000.0, 77.93% up from the prior year.
  • Current Taxes for Q4 2025 was $927000.0 at Ironwood Pharmaceuticals, up from $656000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $6.6 million in Q2 2023 and bottomed at $521000.0 in Q4 2024.
  • The 4-year median for Current Taxes is $931000.0 (2024), against an average of $1.4 million.
  • The largest annual shift saw Current Taxes skyrocketed 89.63% in 2023 before it crashed 85.93% in 2024.
  • A 4-year view of Current Taxes shows it stood at $656000.0 in 2022, then surged by 89.63% to $1.2 million in 2023, then crashed by 58.12% to $521000.0 in 2024, then skyrocketed by 77.93% to $927000.0 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Current Taxes are $927000.0 (Q4 2025), $656000.0 (Q3 2025), and $764000.0 (Q2 2025).